Jeremy Middleton

Jeremy Middleton is an accomplished executive in the life sciences sector with extensive experience across various leadership roles. Currently serving as Chief Executive Officer at AJK Biopharmaceutical since October 2022, Middleton also holds the position of President at Elinic, LLC, a consulting firm specializing in corporate development for life sciences clients. Previous roles include Vice President of Corporate Development at a biotech company where efforts led to the FDA approval of Anthim, and Vice President of Business Development at Valera Pharmaceuticals. Early career experience includes significant contributions at Neose Technologies, Abbott Laboratories, and The Boots Company PLC. Jeremy Middleton holds a Bachelor of Science with honors in Applied Chemistry from De Montfort University.